Malina, Mel G.
HRN: 09-05-71 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/07/2023
CEFTRIAXONE 1G (VIAL)
11/07/2023
11/14/2023
IV
1g
Q12
Degloving Injury
Checking Final Appropriateness
Indication: Empiric Type of Infection: Bone & JointSkin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes